Skip to main content
Screener/Healthcare/Biotechnology

AVTX — Avalo Therapeutics, Inc.

NASDAQ
$12.26-0.10 (-0.81%)
Small CapUnder $20Healthcare
$11.21
$24.27
$12.22
$13.18
EPS (TTM)$-5.83
P/E Ratio-2.20
Dividend Yield—
Market Cap$621.6M
Volume705K
Prev Close$12.36
Revenue & Operating Income
Revenue
Operating Income
Net Income
Positive
Negative
Free Cash Flow
Positive
Negative
Gross Profit & Operating Expenses
Gross Profit
Operating Expenses
Earnings Per Share
Positive
Negative
Balance Sheet
Total Assets
Total Liabilities
Cash & Equivalents
Cash & Equivalents
Shares Outstanding
Shares Outstanding
Margins
Gross Margin
Operating Margin
Net Margin

Quarterly Results

QuarterRevenueNet IncomeEPSGross MarginNet Margin
Q1 '26$0-$19.6M$-0.98——
Q4 '25$59K-$13.7M$-0.7472.9%-23254.2%
Q3 '25$0-$30.6M$-2.19——
Q2 '25$0-$20.8M$-1.92——
Q1 '25$0-$13.1M$-1.25——
Q4 '24$192K-$35.3M$10.4754.7%-18405.7%
Q3 '24$249K$23.0M$2.14386.7%9251.8%
Q2 '24$0$98.5M$12.87——
Get Your Daily Market Recap